Evidence map›Paper›PMID 34220953›Full record

ArticleFrontiers in genetics2021

Maternal

Qiuxia Cui, Cagri Aksu, Birol Ay, Claire E Remillard, Antonius Plagge, Mina Gardezi, Margaret Dunlap, Louis C Gerstenfeld, Qing He, Murat Bastepe

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Qiuxia CuiEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Cagri AksuEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Birol AyEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Claire E RemillardEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Antonius PlaggeDepartment of Molecular Physiology and Cell Signalling, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Mina GardeziDepartment of Orthopaedic Surgery, Boston University School of Medicine, Boston, MA, United States.
Margaret DunlapDepartment of Orthopaedic Surgery, Boston University School of Medicine, Boston, MA, United States.
Louis C GerstenfeldDepartment of Orthopaedic Surgery, Boston University School of Medicine, Boston, MA, United States.
Qing HeEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Murat BastepeEndocrine Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Boston University · USHarvard University · USMassachusetts General Hospital · USUniversity of Liverpool · GBWuhan University · CNZhongnan Hospital of Wuhan University · CN

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
Role of VEGF in Fracture RepairP01AR049920 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BARNES, GEORGE L · 2004 to 2008
$5.4M
XLas Relative to Gsa in Bone and Mineral Ion MetabolismR01DK073911 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BASTEPE, MURAT · 2007 to 2020
$4.9M
A Systems Genetics Approach to Fracture HealingR01AR059741 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2012 to 2016
$1.8M
Role of Angiogenesis in Distraction OsteogenesisR01AR056637 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2011 to 2015
$1.8M
FUNCTIONAL ROLE OF TNF-ALPHA CYTOKINES IN BONE REPAIRR01AR047045 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2001 to 2004
$1.2M
An Evaluation of Serum Based Indices to Assess Fracture HealingR21AR067900 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2015 to 2016
$397k
In Vivo Imaging Analysis System - Xenogen IVIS SpectrumS10RR024523 · NCRR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2008 to 2008
$350k
NCATS NIH HHS UL1 TR002541NCRR NIH HHS S10 RR024523NIAMS NIH HHS P01 AR049920NIAMS NIH HHS R01 AR047045NIAMS NIH HHS R01 AR056637NIAMS NIH HHS R01 AR059741NIAMS NIH HHS R21 AR067900NIDDK NIH HHS R01 DK073911
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bone marrow stromal cellsfibrous dysplasia of boneGNASimprintingosteoblastsstimulatory G protein

Identifiers

PMID34220953
PMCPMC8247768
OpenAlexW3173282572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.